Xiaochen Zhang1,2, Meghan Pawlikowski1, Susan Olivo-Marston1, Karen Patricia Williams3, Julie K Bower1, Ashley S Felix1. 1. Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, United States of America. 2. Division of Population Sciences, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America. 3. Martha S. Pitzer Center for Women, Children, and Youth, College of Nursing, The Ohio State University, Columbus, Ohio, United States of America.
Abstract
BACKGROUND: Cancer survivors have a higher risk of developing and dying from cardiovascular disease (CVD) compared to the general population. We sought to determine whether 10-year risk of atherosclerotic CVD (ASCVD) is elevated among those with vs. without a cancer history in a nationally representative U.S. sample. METHODS: Participants aged 40-79 years with no CVD history were included from the 2007-2016 National Health and Nutrition Examination Survey. Cancer history was self-reported and 10-year risk of ASCVD was estimated using Pooled Cohort Equations. We used logistic regression to estimate associations between cancer history and odds of elevated (≥7.5%) vs. low (<7.5%) 10-year ASCVD risk. An interaction between age and cancer history was examined. RESULTS: A total of 15,095 participants were included (mean age = 55.2 years) with 12.3% (n = 1,604) reporting a cancer history. Individuals with vs. without a cancer history had increased odds of elevated 10-year ASCVD risk (OR = 3.42, 95% CI: 2.51-4.66). Specifically, those with bladder/kidney, prostate, colorectal, lung, melanoma, or testicular cancer had a 2.72-10.47 higher odds of elevated 10-year ASCVD risk. Additionally, age was an effect modifier: a cancer history was associated with 1.24 (95% CI: 1.19-4.21) times higher odds of elevated 10-year ASCVD risk among those aged 60-69, but not with other age groups. CONCLUSIONS: Adults with a history of self-reported cancer had higher 10-year ASCVD risk. ASCVD risk assessment and clinical surveillance of cardiovascular health following a cancer diagnosis could potentially reduce disease burden and prolong survival, especially for patients with specific cancers and high ASCVD risk.
BACKGROUND:Cancer survivors have a higher risk of developing and dying from cardiovascular disease (CVD) compared to the general population. We sought to determine whether 10-year risk of atherosclerotic CVD (ASCVD) is elevated among those with vs. without a cancer history in a nationally representative U.S. sample. METHODS:Participants aged 40-79 years with no CVD history were included from the 2007-2016 National Health and Nutrition Examination Survey. Cancer history was self-reported and 10-year risk of ASCVD was estimated using Pooled Cohort Equations. We used logistic regression to estimate associations between cancer history and odds of elevated (≥7.5%) vs. low (<7.5%) 10-year ASCVD risk. An interaction between age and cancer history was examined. RESULTS: A total of 15,095 participants were included (mean age = 55.2 years) with 12.3% (n = 1,604) reporting a cancer history. Individuals with vs. without a cancer history had increased odds of elevated 10-year ASCVD risk (OR = 3.42, 95% CI: 2.51-4.66). Specifically, those with bladder/kidney, prostate, colorectal, lung, melanoma, or testicular cancer had a 2.72-10.47 higher odds of elevated 10-year ASCVD risk. Additionally, age was an effect modifier: a cancer history was associated with 1.24 (95% CI: 1.19-4.21) times higher odds of elevated 10-year ASCVD risk among those aged 60-69, but not with other age groups. CONCLUSIONS: Adults with a history of self-reported cancer had higher 10-year ASCVD risk. ASCVD risk assessment and clinical surveillance of cardiovascular health following a cancer diagnosis could potentially reduce disease burden and prolong survival, especially for patients with specific cancers and high ASCVD risk.
Authors: Hege S Haugnes; Torgeir Wethal; Nina Aass; Olav Dahl; Olbjørn Klepp; Carl W Langberg; Tom Wilsgaard; Roy M Bremnes; Sophie D Fosså Journal: J Clin Oncol Date: 2010-09-20 Impact factor: 44.544
Authors: Kathleen M Sturgeon; Lei Deng; Shirley M Bluethmann; Shouhao Zhou; Daniel M Trifiletti; Changchuan Jiang; Scott P Kelly; Nicholas G Zaorsky Journal: Eur Heart J Date: 2019-12-21 Impact factor: 29.983
Authors: Laxmi S Mehta; Karol E Watson; Ana Barac; Theresa M Beckie; Vera Bittner; Salvador Cruz-Flores; Susan Dent; Lavanya Kondapalli; Bonnie Ky; Tochukwu Okwuosa; Ileana L Piña; Annabelle Santos Volgman Journal: Circulation Date: 2018-02-01 Impact factor: 29.690
Authors: Darren R Feldman; Shirin Ardeshir-Rouhani-Fard; Patrick Monahan; Howard D Sesso; Chunkit Fung; Annalynn M Williams; Robert J Hamilton; David J Vaughn; Clair J Beard; Ryan Cook; Mohammad Abu Zaid; Steven E Lipshultz; Lawrence H Einhorn; Kevin C Oeffinger; Lois B Travis; Sophie D Fossa Journal: Clin Genitourin Cancer Date: 2018-02-05 Impact factor: 2.872
Authors: Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-03-27 Impact factor: 4.254
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson Journal: J Am Coll Cardiol Date: 2013-11-12 Impact factor: 24.094
Authors: Nirmanmoh Bhatia; Marilia Santos; Lee W Jones; Joshua A Beckman; David F Penson; Alicia K Morgans; Javid Moslehi Journal: Circulation Date: 2016-02-02 Impact factor: 29.690
Authors: Shannon L Walker; Joni S Williams; Kaiwei Lu; Aprill Z Dawson; Leonard E Egede Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-08-02 Impact factor: 4.090
Authors: Gary Bennett; Kathryn I Pollak; Bridget F Koontz; Erica Levine; Frances McSherry; Donna Niedzwiecki; Linda Sutton; Tykeytra Dale; Martin Streicher; Christel Rushing; Lynda Owen; William E Kraus Journal: Support Care Cancer Date: 2021-05-28 Impact factor: 3.603
Authors: Alessandro Sciarra; Gian Maria Busetto; Stefano Salciccia; Francesco Del Giudice; Martina Maggi; Felice Crocetto; Matteo Ferro; Ettore De Berardinis; Roberto Mario Scarpa; Francesco Porpiglia; Luca Carmignani; Rocco Damiano; Walter Artibani; Giuseppe Carrieri Journal: Front Endocrinol (Lausanne) Date: 2021-06-14 Impact factor: 5.555